Leiters

Leiters is an FDA-registered 503B outsourcing provider of compounded medicines. Compounding is the process of converting drugs in a sterile pharmaceutical-grade environment from bulk supplies into individual doses for patients. Hospitals, surgery centers and physician practices use compounded drugs for infused antibiotics, childbirth medications, anesthesia, analgesics and other procedures.

Leiters’ key product offerings include pre-filled syringes, ophthalmic generics and non-opioid alternatives to managing pain after surgery. The company’s sterile manufacturing facilities operate under Current Good Manufacturing Practice (cGMP) standards and are regularly inspected by the FDA, DEA, state boards of pharmacy and customers.

Several of the country’s leading non-profit health systems are strategic investors in Leiters alongside WCAS. They include (but are not limited to) Intermountain Healthcare, Kaiser Permanente, Mayo Clinic, Memorial Hermann Health System, Novant Health, Corewell Health and the University of North Carolina Health Care System.

Current CEO: Joseph Cosgrove

Headquarters: Denver, CO

Investment Year: 2021

Fund: WCAS Fund XIII